Oncol Lett 2016 Jun 19;11(6):3901-3903. Epub 2016 Apr 19.
Department of Radiation Oncology, University of Tokyo Hospital, Tokyo 113-8655, Japan.
Download full-text PDF
J Adv Pract Oncol 2012 May;3(3):161-9
The University of Texas MD Anderson Cancer Center, Houston, Texas.
Case Study Ms. S.G. Read More
Gan To Kagaku Ryoho 2011 Nov;38(12):2397-400
Division of Digestive Surgery, Dept. of Surgery, Kyoto Prefectural University of Medicine.
Patients with T4 esophageal cancer generally have poor prognosis. Of these patients, prognosis of non-responder to chemoradiothrapy (CRT) is extremely poor. We report a case of residual lymph node metastasis following definitive CRT, which showed a good response to outpatient clinic-based chemotherapy consisting of docetaxel (DOC) followed by S-1 in a patient with T4 esophageal cancer. Read More
Mol Clin Oncol 2017 Dec 4;7(6):1061-1063. Epub 2017 Oct 4.
Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for solitary cancerous lesions. The present study reported a rare case of sustained remission after SBRT for oligorecurrence in the liver in a patient with esophageal carcinoma. A 60-year-old Japanese man presented with a chief complaint of dysphagia. Read More
Mol Clin Oncol 2017 Oct 18;7(4):681-686. Epub 2017 Aug 18.
Department of Radiology, University of Tokyo Hospital, Tokyo 113-8655, Japan.
There is currently no consensus on salvage therapy for recurrent esophageal cancer. Salvage surgery is a well-established option for attaining long-term survival; however, it is associated with a high risk of perioperative morbidity and mortality. A total of 6 patients who underwent re-irradiation for recurrence of locoregional esophageal cancer following definitive chemoradiotherapy were investigated. Read More